Exane Derivatives’s Vanguard Morningstar Value ETF VTV Stock Holding History
Bought
Maintained
Sold
Other funds holding VTV
Exane Derivatives's VTV Position: Q2 2022 in Review
Exane Derivatives sold out of Vanguard Morningstar Value ETF (VTV) in Q2 2022, closing a stake of 428 shares — an estimated $63.2K sold.
Exane Derivatives first reported a position in VTV in Q4 2020 and held it in 5 quarters. The position peaked at $1.04M in Q2 2021. 1,658 funds tracked by Wall St. Rank hold VTV as of Q2 2022.
- Exane Derivatives reported no remaining Vanguard Morningstar Value ETF position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 428 Vanguard Morningstar Value ETF shares in Q2 2022, an estimated $63.2K.
- Exane Derivatives first reported a position in Vanguard Morningstar Value ETF in Q4 2020 and held it in 5 quarters.
- Exane Derivatives's Vanguard Morningstar Value ETF position peaked at $1.04M in Q2 2021.
- 1,658 funds tracked by Wall St. Rank held Vanguard Morningstar Value ETF as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.